Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer and infectious diseases, today announced an ag ...

CAR T-cell therapy represents a groundbreaking advancement in the field of oncology, particularly in the treatment of certain types of blood cancers such as leukemia and lymphoma. This innovative ...

Denileukin diftitox is under clinical development by Citius Oncology and currently in Phase II for Non-Small Cell Lung Cancer.

Denileukin diftitox is under clinical development by Citius Oncology and currently in Phase II for Renal Cell Carcinoma.

1 Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China 2 Division of Abdominal Tumor Multimodality Treatment, Department of Medical Oncology, Cancer Center, West China ...

Detailed price information for Krystal Biotech Inc (KRYS-Q) from The Globe and Mail including charting and trades.